ArticleScientific reports2026
Nitrogen-doped carbon dot-based dual-emission ratiometric probe for smartphone-assisted ultrasensitive detection of moxifloxacin.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moxifloxacin (MOX), a widely prescribed fourth-generation fluoroquinolone antibiotic, poses significant environmental and health risks due to misuse, including the development of antibiotic resistance. Herein, we developed a smartphone-integrated, dual-emission ratiometric fluorescent probe for the ultrasensitive detection of MOX. The probe utilizes the intrinsic cyan fluorescence of MOX as the detection signal and blue-emitting nitrogen-doped carbon dots (N-CDs) as an internal reference. The N-CDs were synthesized via a facile one-pot hydrothermal method from citric acid (CA) and 4-aminoantipyrine (4AA). Comprehensive characterization (FTIR, 1H-NMR, 13C-NMR, XPS, Raman, XRD, TEM) confirmed their quasi-spherical morphology with an average diameter of 5.1 nm, successful nitrogen doping (12.56%), a quantum yield of 10%, and an abundance of surface functional groups (-OH, -NH2, -COOH). The ratiometric probe’s sensing mechanism relies on the stable blue emission of the N-CDs at 418 nm (reference signal) and the MOX-induced increase in cyan emission at 463 nm. The ratiometric signal (I463/I418) demonstrated exceptional analytical performance with a detection limit of 57 nmol L–1, a wide linear range (0.4–20 μmol L–1), and a rapid response within 3 min. A smartphone-based platform was also developed for on-site analysis, achieving an LOD of 2.8 μmol L–1 (linear range: 0–200 μmol L–1). The probe exhibited excellent selectivity against 15 common interferents and was successfully applied to commercial MOX tablets with high recovery rates (93–112%). Greenness assessment using AGREE (0.8) and Complex-MoGAPI (0.89) metrics confirmed the method’s outstanding environmental friendliness, characterized by minimal solvent use, absence of toxic substances, low energy consumption, and negligible waste generation. This integrated strategy provides a portable, cost-effective, and reliable platform for MOX monitoring in pharmaceutical, environmental, and point-of-care diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.